-
1
-
-
38749120897
-
A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel
-
Huh, K.M., Min, H.S., Lee, S.C., Lee, H.G., Kim, S. and Park, K. 2008. A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel. Journal of Controlled Release, 126:122-9.
-
(2008)
Journal of Controlled Release
, vol.126
, pp. 122-129
-
-
Huh, K.M.1
Min, H.S.2
Lee, S.C.3
Lee, H.G.4
Kim, S.5
Park, K.6
-
2
-
-
38549128788
-
Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a beta-cyclodextrin/ poly(amidoamine) copolymer
-
Bencini, M., Ranucci, E., Ferruti, P., Trotta, F., Donalisio, M., Cornaglia, M. et al. 2008. Preparation and in vitro evaluation of the antiviral activity of the Acyclovir complex of a beta-cyclodextrin/ poly(amidoamine) copolymer. Journal of Controlled Release, 126:17-25.
-
(2008)
Journal of Controlled Release
, vol.126
, pp. 17-25
-
-
Bencini, M.1
Ranucci, E.2
Ferruti, P.3
Trotta, F.4
Donalisio, M.5
Cornaglia, M.6
-
3
-
-
37349075381
-
Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel
-
Lee, L.Y., Wang, C.H. and Smith, K.A. 2008. Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel. Journal of Controlled Release, 125:96-106.
-
(2008)
Journal of Controlled Release
, vol.125
, pp. 96-106
-
-
Lee, L.Y.1
Wang, C.H.2
Smith, K.A.3
-
4
-
-
37649010361
-
Nanoparticles for drug delivery in cancer treatment
-
Haley, B. and Frenkel, E. 2008. Nanoparticles for drug delivery in cancer treatment. Urol. Oncol., 26:57-64.
-
(2008)
Urol. Oncol.
, vol.26
, pp. 57-64
-
-
Haley, B.1
Frenkel, E.2
-
5
-
-
1942453805
-
Solid lipid nanoparticles for parenteral drug delivery
-
Wissing, S.A., Kayser, O. and Muller, R.H. 2004. Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev., 56:1257-72.
-
(2004)
Adv. Drug Deliv. Rev.
, vol.56
, pp. 1257-1272
-
-
Wissing, S.A.1
Kayser, O.2
Muller, R.H.3
-
6
-
-
23144456813
-
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
-
Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T. et al. 2005. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature, 436:568-72.
-
(2005)
Nature
, vol.436
, pp. 568-572
-
-
Sengupta, S.1
Eavarone, D.2
Capila, I.3
Zhao, G.4
Watson, N.5
Kiziltepe, T.6
-
7
-
-
0035862692
-
Taxane-Antibody Conjugates Afford Potent Cytotoxicity, Enhanced Solubility, and Tumor Target Selectivity1
-
Guillemard, V. and Saragovi, H.U. 2001. Taxane-Antibody Conjugates Afford Potent Cytotoxicity, Enhanced Solubility, and Tumor Target Selectivity1. Cancer Res., 61:694-9.
-
(2001)
Cancer Res.
, vol.61
, pp. 694-699
-
-
Guillemard, V.1
Saragovi, H.U.2
-
8
-
-
34548630543
-
Drug safety evaluation through biomarker analysis-A toxicity study in the cynomolgus monkey using an antibody-cytotoxic conjugate against ovarian cancer
-
Hsieh, F.Y., Tengstrand, E., Lee, J.W., Li, L.Y., Silverman, L., Riordan, B. et al. 2007. Drug safety evaluation through biomarker analysis-A toxicity study in the cynomolgus monkey using an antibody-cytotoxic conjugate against ovarian cancer. Toxicol. Appl. Pharmacol., 224:12-8.
-
(2007)
Toxicol. Appl. Pharmacol
, vol.224
, pp. 12-18
-
-
Hsieh, F.Y.1
Tengstrand, E.2
Lee, J.W.3
Li, L.Y.4
Silverman, L.5
Riordan, B.6
-
9
-
-
4143108331
-
Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in culture and related tumors in rodents
-
Sun, L.C., Fuselier, J.A. and Coy, D.H. 2004. Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in culture and related tumors in rodents. Drug Deliv., 11:231-8.
-
(2004)
Drug Deliv.
, vol.11
, pp. 231-238
-
-
Sun, L.C.1
Fuselier, J.A.2
Coy, D.H.3
-
10
-
-
0035094324
-
A targeted cytotoxic somatostatin (SST) analogue, AN.-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice
-
Kiaris, H., Schally, A.V., Nagy, A., Szepeshazi, K., Hebert, F. and Halmos, G. 2001. A targeted cytotoxic somatostatin (SST) analogue, AN.-238, inhibits the growth of H-69 small-cell lung carcinoma (SCLC) and H-157 non-SCLC in nude mice. Eur. J. Cancer, 37:620-8.
-
(2001)
Eur. J. Cancer
, vol.37
, pp. 620-628
-
-
Kiaris, H.1
Schally, A.V.2
Nagy, A.3
Szepeshazi, K.4
Hebert, F.5
Halmos, G.6
-
11
-
-
23844456666
-
Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells
-
Moody, T.W., Fuselier, J.A., Coy, D.H., Mantey, S., Pradhan, T., Nakagawa, T. et al. 2005. Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells. Peptides, 26:1560-6.
-
(2005)
Peptides
, vol.26
, pp. 1560-1566
-
-
Moody, T.W.1
Fuselier, J.A.2
Coy, D.H.3
Mantey, S.4
Pradhan, T.5
Nakagawa, T.6
-
12
-
-
2542477191
-
Development of high affinity camptothecinbombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells
-
Moody, T.W., Mantey, S.A., Pradhan, T.K., Schumann, M., Nakagawa, T., Martinez, A. et al. 2004. Development of high affinity camptothecinbombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells. J. Biol. Chem., 279:23580-9.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 23580-23589
-
-
Moody, T.W.1
Mantey, S.A.2
Pradhan, T.K.3
Schumann, M.4
Nakagawa, T.5
Martinez, A.6
-
13
-
-
42449112468
-
Cytotoxic conjugates of peptide hormones for cancer chemotherapy
-
Sun, L.C. and Coy, D.H. 2008. Cytotoxic conjugates of peptide hormones for cancer chemotherapy. Drugs of the Future, 33:217-23.
-
(2008)
Drugs of the Future
, vol.33
, pp. 217-223
-
-
Sun, L.C.1
Coy, D.H.2
-
14
-
-
0042854927
-
Peptide receptors as molecular targets for cancer diagnosis and therapy
-
Reubi, J.C. 2003. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev., 24:389-427.
-
(2003)
Endocr. Rev.
, vol.24
, pp. 389-427
-
-
Reubi, J.C.1
-
15
-
-
0034513226
-
Molecular and biological determinants of the cytotoxic actions of camptothecins. Perspective for the development of new topoisomerase I inhibitors
-
Kohn, K.W. and Pommier, Y. 2000. Molecular and biological determinants of the cytotoxic actions of camptothecins. Perspective for the development of new topoisomerase I inhibitors. Ann. N.Y. Acad. Sci., 922:11-26.
-
(2000)
Ann. N.Y. Acad. Sci.
, vol.922
, pp. 11-26
-
-
Kohn, K.W.1
Pommier, Y.2
-
16
-
-
0032169909
-
Camptothecins: A review of their development and schedules of administration
-
O'Leary, J. and Muggia, F.M. 1998. Camptothecins: a review of their development and schedules of administration. Eur. J. Cancer, 34:1500-8.
-
(1998)
Eur. J. Cancer
, vol.34
, pp. 1500-1508
-
-
O'Leary, J.1
Muggia, F.M.2
-
17
-
-
33747620735
-
In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors
-
Moody, T.W., Sun, L.C., Mantey, S.A., Pradhan, T., Gonzales, N., Coy, D.H. et al. 2006. In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors. J. Pharmacol. Exp. Ther., 318:1265-72.
-
(2006)
J. Pharmacol. Exp. Ther.
, vol.318
, pp. 1265-1272
-
-
Moody, T.W.1
Sun, L.C.2
Mantey, S.A.3
Pradhan, T.4
Gonzales, N.5
Coy, D.H.6
-
18
-
-
24644445086
-
Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1
-
Engel, J.B., Schally, A.V., Halmos, G., Baker, B., Nagy, A. and Keller, G. 2005. Targeted therapy with a cytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing multidrug resistance protein MDR-1. Cancer, 104:1312-21.
-
(2005)
Cancer
, vol.104
, pp. 1312-1321
-
-
Engel, J.B.1
Schally, A.V.2
Halmos, G.3
Baker, B.4
Nagy, A.5
Keller, G.6
-
19
-
-
29144509887
-
Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistance proteins
-
Engel, J.B., Schally, A.V., Halmos, G., Baker, B., Nagy, A. and Keller, G. 2005. Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistance proteins. Endocr. Relat. Cancer., 12:999-1009.
-
(2005)
Endocr. Relat. Cancer.
, vol.12
, pp. 999-1009
-
-
Engel, J.B.1
Schally, A.V.2
Halmos, G.3
Baker, B.4
Nagy, A.5
Keller, G.6
-
20
-
-
25144450706
-
Receptors for luteinizing hormone releasing hormone (LHRH) expressed in human non-Hodgkin's lymphomas can be targeted for therapy with the cytotoxic LHRH analogue AN-207
-
Keller, G., Schally, A.V., Gaiser, T., Nagy, A., Baker, B., Halmos, G. et al. 2005. Receptors for luteinizing hormone releasing hormone (LHRH) expressed in human non-Hodgkin's lymphomas can be targeted for therapy with the cytotoxic LHRH analogue AN-207. Eur. J. Cancer., 41:2196-202.
-
(2005)
Eur. J. Cancer.
, vol.41
, pp. 2196-2202
-
-
Keller, G.1
Schally, A.V.2
Gaiser, T.3
Nagy, A.4
Baker, B.5
Halmos, G.6
-
21
-
-
33745929350
-
Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormonereleasing hormone and their combinations
-
Buchholz, S., Keller, G., Schally, A.V., Halmos, G., Hohla, F., Heinrich, E. et al. 2006. Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormonereleasing hormone and their combinations. PNAS, 103:10403-7.
-
(2006)
PNAS
, vol.103
, pp. 10403-10407
-
-
Buchholz, S.1
Keller, G.2
Schally, A.V.3
Halmos, G.4
Hohla, F.5
Heinrich, E.6
-
22
-
-
0028035411
-
Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines
-
Fujita, T., Yamaji, Y., Sato, M., Murao, K. and Takahara, J. 1994. Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines. Life Sci., 55:1797-806.
-
(1994)
Life Sci.
, vol.55
, pp. 1797-1806
-
-
Fujita, T.1
Yamaji, Y.2
Sato, M.3
Murao, K.4
Takahara, J.5
-
23
-
-
0028032570
-
Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: Evidence for SSTR2 heterogeneity
-
Taylor, J.E., Theveniau, M.A., Bashirzadeh, R., Reisine, T. and Eden, P.A. 1994. Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: evidence for SSTR2 heterogeneity. Peptides, 15:1229-36.
-
(1994)
Peptides
, vol.15
, pp. 1229-1236
-
-
Taylor, J.E.1
Theveniau, M.A.2
Bashirzadeh, R.3
Reisine, T.4
Eden, P.A.5
-
24
-
-
0032893138
-
Expression of somatostatin receptors in peritumoral veins of human tumors
-
Denzler, B. and Reubi, J.C. 1999. Expression of somatostatin receptors in peritumoral veins of human tumors. Cancer, 85:188-98.
-
(1999)
Cancer
, vol.85
, pp. 188-198
-
-
Denzler, B.1
Reubi, J.C.2
-
25
-
-
33845650679
-
A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9
-
Sun, L.C., Luo, J., Mackey, L.V., Fuselier, J.A. and Coy, D.H. 2007. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. Cancer Let., 246:157-66.
-
(2007)
Cancer Let.
, vol.246
, pp. 157-166
-
-
Sun, L.C.1
Luo, J.2
McKey, L.V.3
Fuselier, J.A.4
Coy, D.H.5
-
26
-
-
1842741030
-
Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design
-
Sun, L.C., Vasilevich, N.I., Fuselier, J.A., Hocart, S.J. and Coy, D.H. 2004. Examination of the 1,4-disubstituted azetidinone ring system as a template for combretastatin A-4 conformationally restricted analogue design. Bioorg. Med. Chem. Lett, 14:2041-6.
-
(2004)
Bioorg. Med. Chem. Lett
, vol.14
, pp. 2041-2046
-
-
Sun, L.C.1
Vasilevich, N.I.2
Fuselier, J.A.3
Hocart, S.J.4
Coy, D.H.5
-
27
-
-
0032545948
-
Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes
-
Pradhan, T.K., Katsuno, T., Taylor, J.E., Kim, S.H., Ryan, R.R., Mantey, S.A. et al. 1998. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes. Eur. J. Pharmacol., 343:275-87.
-
(1998)
Eur. J. Pharmacol.
, vol.343
, pp. 275-287
-
-
Pradhan, T.K.1
Katsuno, T.2
Taylor, J.E.3
Kim, S.H.4
Ryan, R.R.5
Mantey, S.A.6
-
28
-
-
11244347812
-
Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7
-
Liu, C., Chen, J., Kuei, C., Sutton, S., Nepomuceno, D., Bonaventure, P. et al. 2005. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Mol. Pharmacol., 67:231-40.
-
(2005)
Mol. Pharmacol.
, vol.67
, pp. 231-240
-
-
Liu, C.1
Chen, J.2
Kuei, C.3
Sutton, S.4
Nepomuceno, D.5
Bonaventure, P.6
-
29
-
-
2342509665
-
The effect of drug dose and drug exposure time on the binding, internalization, and cytotoxicity of radiolabeled somatostatin analogs
-
Anthony, C.T., Hughey, S., Lyons, J., Weiss, S., Hornick, C.A., Drouant, G.J. et al. 2004. The effect of drug dose and drug exposure time on the binding, internalization, and cytotoxicity of radiolabeled somatostatin analogs. J. Surg. Res., 119:1-13.
-
(2004)
J. Surg. Res.
, vol.119
, pp. 1-13
-
-
Anthony, C.T.1
Hughey, S.2
Lyons, J.3
Weiss, S.4
Hornick, C.A.5
Drouant, G.J.6
-
30
-
-
0028888586
-
Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors
-
Panetta, R. and Patel, Y.C. 1995. Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors. Life Sciences, 56:333-42.
-
(1995)
Life Sciences
, vol.56
, pp. 333-342
-
-
Panetta, R.1
Patel, Y.C.2
-
31
-
-
22244455403
-
A Mouse Model of Human Breast Cancer Metastasis to Human Bone
-
Kuperwasser, C., Dessain, S., Bierbaum, B.E., Garnet, D., Sperandio, K., Gauvin, G.P. et al. 2005. A Mouse Model of Human Breast Cancer Metastasis to Human Bone. Cancer Res., 65:6130-8.
-
(2005)
Cancer Res.
, vol.65
, pp. 6130-6138
-
-
Kuperwasser, C.1
Dessain, S.2
Bierbaum, B.E.3
Garnet, D.4
Sperandio, K.5
Gauvin, G.P.6
-
32
-
-
0034934877
-
Growing vascular endothelial cells express somatostatin subtype 2 receptors
-
Watson, J.C., Balster, D.A. and Gebhardt, M.B. 2001. Growing vascular endothelial cells express somatostatin subtype 2 receptors. Br. J. Cancer, 85:266-72.
-
(2001)
Br. J. Cancer
, vol.85
, pp. 266-272
-
-
Watson, J.C.1
Balster, D.A.2
Gebhardt, M.B.3
-
33
-
-
0034803184
-
Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers
-
Szepeshazi, K., Schally, A.V., Halmos, G., Sun, B., Hebert, F., Csernus, B. et al. 2001. Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers. Clin. Cancer Res., 7:2854-61.
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 2854-2861
-
-
Szepeshazi, K.1
Schally, A.V.2
Halmos, G.3
Sun, B.4
Hebert, F.5
Csernus, B.6
-
34
-
-
0032539609
-
Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin
-
Nagy, A., Schally, A.V. and Halmos, G. 1998. Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. PNAS, 95:1794-9.
-
(1998)
PNAS
, vol.95
, pp. 1794-1799
-
-
Nagy, A.1
Schally, A.V.2
Halmos, G.3
-
35
-
-
33846703621
-
Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector
-
Sun, L.C., Luo, J., Mackey, L.V., Fuselier, J.A. and Coy, D.H. 2007. Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector. Anticancer Drugs, 18:341-8.
-
(2007)
Anticancer Drugs
, vol.18
, pp. 341-348
-
-
Sun, L.C.1
Luo, J.2
McKey, L.V.3
Fuselier, J.A.4
Coy, D.H.5
-
36
-
-
17144397158
-
Study of inhibitory effects of an antiangiogenic somatostatin-camptothecin conjugate on laser-induced choroidal neovascularization in rats
-
Bezerra, Y., Fuselier, J.A., Peyman, G.A., Oner, H., Drouant, G. and Coy, D.H. 2005. Study of inhibitory effects of an antiangiogenic somatostatin-camptothecin conjugate on laser-induced choroidal neovascularization in rats. Retina, 25:345-54.
-
(2005)
Retina
, vol.25
, pp. 345-354
-
-
Bezerra, Y.1
Fuselier, J.A.2
Peyman, G.A.3
Oner, H.4
Drouant, G.5
Coy, D.H.6
-
37
-
-
34548504526
-
Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells
-
Moody, T.W., Mantey, S.A., Fuselier, J.A., Coy, D.H. and Jensen, R.T. 2007. Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells. Peptides, 28:1883-90.
-
(2007)
Peptides
, vol.28
, pp. 1883-1890
-
-
Moody, T.W.1
Mantey, S.A.2
Fuselier, J.A.3
Coy, D.H.4
Jensen, R.T.5
-
38
-
-
0035953309
-
Novel peptide conjugates for tumor-specific chemotherapy
-
Langer, M., Kratz, F., Rothen-Rutishauser, B., Wunderli- Allenspach, H. and Beck-Sickinger, A.G. 2001. Novel peptide conjugates for tumor-specific chemotherapy. J. Med. Chem., 44:1341-8.
-
(2001)
J. Med. Chem.
, vol.44
, pp. 1341-1348
-
-
Langer, M.1
Kratz, F.2
Rothen-Rutishauser, B.3
Wunderli-Allenspach, H.4
Beck-Sickinger, A.G.5
-
39
-
-
0028023579
-
Characterization of somatostatin receptors on human neuroblastoma tumors
-
O'Dorisio, M.S., Chen, F., O'Dorisio, T.M., Wray, D. and Qualman, S.J. 1994. Characterization of somatostatin receptors on human neuroblastoma tumors. Cell Growth Differ., 5:1-8.
-
(1994)
Cell Growth Differ
, vol.5
, pp. 1-8
-
-
O'Dorisio, M.S.1
Chen, F.2
O'Dorisio, T.M.3
Wray, D.4
Qualman, S.J.5
-
40
-
-
0028906832
-
Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate
-
Qin, Y., Ertl, T., Groot, K., Horvath, J., Cai, R.Z. and Schally, A.V. 1995. Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate. Int. J. Cancer, 60:694-700.
-
(1995)
Int. J. Cancer
, vol.60
, pp. 694-700
-
-
Qin, Y.1
Ertl, T.2
Groot, K.3
Horvath, J.4
Cai, R.Z.5
Schally, A.V.6
-
41
-
-
0025861592
-
Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth
-
Evers, B.M., Townsend, Jr. C.M., Upp, J.R., Allen, E., Hurlbut, S.C., Kim, S.W. et al. 1991. Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth. Gastroenterology, 101:303-11.
-
(1991)
Gastroenterology
, vol.101
, pp. 303-311
-
-
Evers, B.M.1
Townsend, C.M.2
Upp, J.R.3
Allen, E.4
Hurlbut, S.C.5
Kim, S.W.6
-
42
-
-
7944236863
-
Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells
-
Ludvigsen, E., Stridsberg, M., Taylor, J.E., Culler, M.D., Oberg, K. and Janson, E.T. 2004. Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells. Med. Oncol., 21:285-95.
-
(2004)
Med. Oncol.
, vol.21
, pp. 285-295
-
-
Ludvigsen, E.1
Stridsberg, M.2
Taylor, J.E.3
Culler, M.D.4
Oberg, K.5
Janson, E.T.6
|